Filtern
Dokumenttyp
- Zeitschriftenartikel (4)
- Vortrag (4)
- Posterpräsentation (3)
- Beitrag zu einem Tagungsband (2)
Schlagworte
- Screening (13) (entfernen)
Organisationseinheit der BAM
Eingeladener Vortrag
- nein (4)
Mycotoxins (toxic compounds formed by fungi) in food and feed have caused problems for mankind since the beginning of time. The group of ergot alkaloids plays a special role in human history. Several tens of thousands of deaths during the middle ages caused by to ergotism (the disease caused by continuous intake of ergot alkaloid contaminated food) underscore the importance of reliable analytical methods to ensure food safety.
More than 50 compounds belong to the group of ergot alkaloids. The 12 most found structures – the major ergot alkaloids – are typically measured, when it comes to ergot alkaloid quantification. High performance liquid chromatography (HPLC) with a fluorescence detector (FLD) is typically used to quantify the ergot alkaloid content. The main disadvantage of this method are the high costs for calibration standards (12 different calibration substances are required). But also, the time and effort required for the analysis of 12 peaks and overlapping signals that occur in complex food samples such as bread. As all ergot alkaloids share the ergoline structure and just differ in the substituents attached to this backbone, measurement of all ergot alkaloids in one sum parameter presents a time and cost saving alternative. The most important step for the development of such a sum parameter method is the reaction used to transfer all ergot alkaloids to one uniform structure. Two promising reactions, the acidic esterification to lysergic acid methyl ester and hydrazinolysis to lysergic acid hydrazide, were examined for possible use in a routine analysis method. In addition to yield and reaction rate, factors such as handling of the reaction and the possibility of parallel sample workup play a role.
Screening against ADAMTS4 reveals a specific peptide, which was turned into an MRI probe. The aneurysm in a mouse modal was visualized via MRI. A differentiation between stable and unstable aneurysm in an early state was performed. Using the probe as tool for an easy and non-invasive rupture assessment is possible.
Partikelbasierte Multianalyt- Fluoreszenzimmunoassays für die Unweltanalytik und Biotechnologie
(2021)
Zur Beurteilung der Wasserqualität können Markersubstanzen, wie Carbamazepin, Diclofenac, Koffein und Gallensäuren, verwendet werden. Erhöhte Konzentrationen dieser anthropogenen Marker weisen auf Einleitstellen von Abwasser hin und zeigen somit an, wo Gewässer verschmutzt werden. Diese Arbeit beschreibt deshalb die Etablierung, Optimierung und Validierung eines partikelbasierten Suspensionsarray Fluoreszenzimmunoassays (SAFIA), mit dem diese Substanzen gleichzeitig und parallel in vielen Proben quantitativ bestimmt werden können. Für SAFIA wurde das Format des kompetitiven indirekten Immunoassays gewählt. Als Plattform wurden fluoreszenzintensitätscodierte Polystyrol-Kern/Siliziumdioxid-Schale-Partikel, auf deren Oberfläche Haptene als kompetitive Bindungsstellen für Antikörper immobilisiert wurden, verwendet. Hier zeigte sich, dass eine selektive Erkennung der Haptenstruktur auf der Oberfläche der Partikel durch die Antikörper nur gegeben war, wenn die Partikel zusätzlich mit Polyethylenglykolgruppen funktionalisiert wurden. Zum Auslesen des Fluoreszenzsignals wurde ein Durchflusszytometer verwendet. Kompatibilität mit der Durchführung in Mikrotiterplatten wurde erreicht, indem eine Stopp-lösung für den SAFIA, basierend auf Formaldehyd, entwickelt wurde. Nach der Optimierung der Assayparameter können die oben genannten vier Analyten gleichzeitig in einer Probe mindestens bis zu einer Konzentration von 0.3 μg L-1 nachgewiesen werden. Der Assay kann ohne Wasch-schritte ausgeführt werden und ist somit einfacher als konventionelle Immunoassays, wie z. B. ELISA. Der SAFIA wurde hinsichtlich Interferenzen und Selektivität untersucht. Dabei zeigte sich, dass Matrixbestandteile, die in wässrigen Umweltproben vorkommen, keinen bzw. nur einen ge-ringen Einfluss auf den SAFIA hatten. Im simulierten Umweltscreening eines Flusses und mithilfe der Analyse von Abwasserproben wurde SAFIA validiert; hier zeigte SAFIA eine mit ELISA vergleich-bare Genauigkeit, bei gleichzeitiger Senkung der Analysenzeit und -kosten. Die gleichzeitige Detektion mehrerer anthropogener Marker erlaubte zudem Rückschlüsse auf die Art von Verschmutzungsquellen, im Gegensatz zu ELISA, mit dem nur ein Analyt bestimmt werden kann. Da hochaffine Antikörper für Immunoassays essenziell sind, wurde ein SAFIA zum Screening antikörperproduzierenden Zellen (Hybridomzellen) entwickelt und eingesetzt. Durch die Implementierung eines Sandwichimmunoassays zur IgG Bestimmung und durch Verwendung von homo- und heterologen Haptenstrukturen konnten aus einem Pool von Hybridomzellen diejenigen ausgewählt werden, deren sekretierter Antikörper die geringsten Nachweisgrenzen im Immunoassay erlauben. Damit konnte das Anwendungsspektrum des SAFIA maßgeblich vergrößert werden. Er vereinfacht als biotechnologisches Werkzeug stark sowohl die Produktion von monoklonalen Antikörpern als auch die Analyse von Umweltproben.
This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.
The primary screening of hybridoma cells is a time-critical and laborious step during the development of monoclonal antibodies. Often, critical errors occur in this phase, which supports the notion that the generation of monoclonal antibodies with hybridoma technology is difficult to control and hence, a risky venture. We think that it is crucial to improve the screening process to eliminate most of the critical deficits of the conventional approach. With this new microarray-based procedure, several advances could be achieved: Selectivity for excellent binders, high-throughput, reproducible signals, avoidance of misleading avidity (multivalency) effects, and performance of simultaneous competition experiments. The latter can also be used to select clones of desired cross-reactivity properties. In this paper, a model system with two excellent clones against carbamazepine, two weak clones, and blank supernatant containing fetal bovine serum was designed to examine the effectiveness of the new system. The excellent clones could be detected largely independent of the immunoglobulin G (IgG) concentration, which is usually unknown during the clone screening since the determination and subsequent adjustment of the antibody concentration are not feasible in most cases. Furthermore, in this approach, the enrichment, isolation, and purification of IgG for characterization is not necessary. Raw cell culture supernatant can be used directly, even when fetal calf serum (FCS) or other complex media is used. In addition, an improved method for the oriented antibody-immobilization on epoxy-silanized slides is presented. Based on the results of this model system with simulated hybridoma supernatants, we conclude that this approach should be preferable to most other protocols leading to many false positives, causing expensive and lengthy elimination steps to weed out the poor clones.
Peptide-polymer bioconjugates combine oligopeptides with synthetic polymer blocks and can be used for various applications in material sciences. In recent years, bioconjugates were applied as compatibilizers and coatings. Biocombinatorial approaches, such as phage display, have been shown to yield strong binding peptides, which exhibit excellent coating properties as peptide-PEO conjugates. Phage display represents a widely exploited strategy to select peptides or proteins that exhibit highly specific affinity to various substrates. Following a phage display experiment, DNA sequencing of binding phage clones is required in order to get the sequence information of the binding peptides. Traditionally, random clone picking followed by Sanger sequencing was applied. However, this method may not necessarily identify the strongest binding clones. Next-generation sequencing made sequencing of whole phage libraries possible, which highly improved the selection of strong binders. Here, we show that the biocombinatorial method of phage display combined with next generation DNA sequencing of whole phage libraries represents a powerful tool for an application in material chemistry. Phage display is used to find specific target binding peptides for polypropylene surfaces (PP). PP binders are of particular interest because thus far gluing or printing on PP is challenging due to its low surface energy. Scripts for sequence data analysis were developed and promising sequences were synthesized as peptide-PEO conjugates. Fluorescence based adsorption experiments on PP surfaces led to the identification of strong binding sequences and a better understanding of the peptide-surface interactions.
To determine the seasonal performance of heat pumps for energy labelling this study proposes a two-point-method that could conceivably be an alternative to the European standard EN 14825 and similar test standards such as ISO 13256. Heat pumps were tested in line with the EN 14825. The reduction of measurement points, from between five to seven (EN 14825) to only two (two-point-method), leads to 60 % savings in cost and time. It is shown that the shortened method can be used to determine the seasonal energy efficiency of heat pumps with the same degree of precision compared to EN 14825.
To determine the seasonal performance of heat pumps for energy labelling this study proposes a two-point-method that could conceivably be an alternative to the European standard EN 14825 and similar test standards such as ISO 13256. Heat pumps were tested in line with the EN 14825. The reduction of measurement points, from between five to seven (EN 14825) to only two (two-point-method), leads to 60 % savings in cost and time. It is shown that the shortened method can be used to determine the seasonal energy efficiency of heat pumps with the same degree of precision compared to EN 14825.
Screening of one-bead-one-compound (OBOC) libraries is a proven procedure for the identification of protein-binding ligands. The demand for binders with high affinity and specificity towards various targets has surged in the biomedical and pharmaceutical field in recent years. The traditional peptide screening involves tedious steps such as affinity selection, bead picking, sequencing, and characterization. Herein, we present a high-throughput “all-on-one chip” system to avoid slow and technically complex bead picking steps. On a traditional glass slide provided with an electrically conductive tape, beads of a combinatorial peptide library are aligned and immobilized by application of a precision sieve. Subsequently, the chip is incubated with a fluorophore-labeled target protein. In a fluorescence scan followed by matrix-assisted laser desorption/ionization (MALDI)-time of flight (TOF) mass spectrometry, high-affinity binders are directly and unambiguously sequenced with high accuracy without picking of the positive beads. The use of an optimized ladder sequencing approach improved the accuracy of the de-novo sequencing step to nearly 100%. The new technique was validated by employing a FLAG-based model system, identifying new peptide binders for the monoclonal M2 anti-FLAG antibody, and was finally utilized to search for IgG-binding peptides. In the present format, more than 30,000 beads can be screened on one slide.